1,4-Dihydropyridines: A multtifunctional molecule- a review

International Journal of ChemTech Research

Volumn 3, Issue 1, 2011, Pages 75-89

  Swarnalatha, G ^a   Prasanthi, G ^a   Sirisha, N ^a   Madhusudhana Chetty, C ^a  

^a ANNAMACHARYA COLLEGE OF PHARMACY   (India)

Author keywords

1,4 dihydropyridines; CVS activitites; Other activities

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 4 (3 NITROPHENYL) 3,5 PYRIDINEDICARBOXYLIC ACID METHYL 1 (PHENYLMETHYL) 3 PIPERIDINYL ESTER; 1,4 DIHYDRO 2,6 DIMETHYL 4 (5 PHENYLISOXAZOL 3 YL) PYRIDINE 3,5 DICARBOXYLIC ACID; 1,4 DIHYDROPYRIDINE DERIVATIVE; 3,5 DIBENZOYL 4 (3 PHENOXYPHENYL) 1,4 DIHYDRO 2,6 DIMETHYLPYRIDINE; 4 (2 IMIDAZOLYL) 2,6 DIMETHYL 3,5 BIS N (2 METHYL 4 OXO 3H QUINAZOLIN 3 YL) CARBAMOYL 1,4 DIHYDROPYRIDINE; 4 (2 PYRIDYL) 2,6 DIMETHYL 3,5 BIS N (6 METHYLPYRIDIN 2 YL) CARBAMOYL 1,4 DIHYDROPYRIDINE; AMIKACIN; AMPICILLIN; ANTIANGINA PECTORIS AGENT; ANTICONVULSIVE AGENT; ANTIFUNGAL AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIULCER AGENT; CALCIUM ANTAGONIST; CARDIOVASCULAR AGENT; GENTAMICIN; IGANIDIPINE; KANAMYCIN; N (6 METHYLBENZOTHIAZOLYL) 3,5 DIACETYL 2,6 DIMETHYL 4 (3 NITROPHENYL) 1,4 DIHYDROPYRIDINE; N (6 METHYLBENZOTHIAZOLYL) 3,5 DIACETYL 2,6 DIMETHYL 4 (4 METHOXYPHENYL) 1,4 DIHYDROPYRIDINE; N276 16; N276 9; NIFEDIPINE; NOVOBIOCIN; PIROXICAM; STREPTOMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASODILATOR AGENT;

ANALGESIC ACTIVITY; ANTIANGINAL ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTICONVULSANT ACTIVITY; ANTIDYSLIPIDEMIC ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTITUBERCULOSIS ACTIVITY; ANTIULCER ACTIVITY; BACILLUS SUBTILIS; CARDIAC DEPRESSANT ACTIVITY; CONVULSION; DRUG ACTIVITY; DRUG POTENCY; ESCHERICHIA COLI; EXPERIMENTAL NEOPLASM; GRAM NEGATIVE BACTERIUM; HUMAN; HYPERTENSION; MULTIDRUG RESISTANCE; NONHUMAN; PROTEUS VULGARIS; REVIEW; STAPHYLOCOCCUS AUREUS; STRESS PROTECTIVE ACTIVITY; STRUCTURE ACTIVITY RELATION; VASODILATATION;

EID: 79951480080     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. David J. Triggle. Calcium channel antagonists: Clinical uses-Past, present and future. Biochemical Pharmacology, 2007, 74, 1-9.
2. Love, B.Goodman, M. Snader, K. Tedeschi, R. Macko, E. Hantzsch-type dihydropyridine hypertensive agent., J. Med. Chem. 1974, 17, 956-965.
3. Bossert, F. Meyer, H. Wehinger, E. 4-Aryldihydropyridines, a new class of highly active calcium antagonists. Angew. Chem. Int. Ed. Engl. 1981, 20, 762-769.
4. Breitenbucher, J.G., Figliozz, G. Solid-phase synthesis of 4-aryl-1,4-dihydropyridines via the Hantzsch three component condensation. Tetrahedron Lett. 2000, 41, 4311-4315
5. Boer, R. & Gekeler, V. chemosensitiser in tumour therapy: new compounds promisebetter efficacy, Drugs Fut, 1995, 20, 499-509.
6. Briukhanov, V.M. The effect of Ca antagonist on the development of inflammatory edema in rats. Exp. clin. pharmocology, 1994, 57, 47-49.
7. Bahekar Sushilkumar, Shinde Devanand, Synthesis and anti-inflammatory activity of 1, 4-dihydropyridines. Acta pharmaceutica (Zagreb) A. 2002, 52(4), 281-287.
8. Wachter, G.A, Davis, M.C, Antimycobacterial activity of substituted isosters of pyridines and pyrazine carboxylicacids. J med chem.,1998, 41, 2436-2438.
9. S. Gullapalli, P.Ramarao. L-type Ca2+ channel modulation by dihydropyridines potentiatesK{green}-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats. Neuropharmacology, 2002, 42, 467-475.
10. Sunkel, C. E, De casa Juana. M.F, Santos, L. 4- alkyl-1, 4-dihydropyridines as specific PAFacether antagonists. J med chem., 1990, 33, 3205-3210.
11. +2antagonist, vasodilators, diltizem, nifedipine, perhexiline and verapamil on platelet aggregation invitro. Arzneim-forsch Drug Res, 1981, 3, 1131-1134.
12. +2 channels. European Journal of Pharmacology, 1999, 375, 311-325.
13. th Edition, 628.
14. Tusell, J.M, Barron, S and Seratosa, J. Anticonvulsant activity of-HCH, calcium channel blockers and calmodulin antagonists in seizures induced by lindane and other convulsant drug. Brain Res, 1993, 622, 99-104.
15. L. M. Tarasenko, K. S. Neporada, and V. Klusha. Stress-Protective Effect of Glutapyrone Belongingto a New Type of Amino Acid-Containing 1,4-Dihyropyridines on Periodontal Tissuesand Stomach in Rats with Different Resistance to Stress. Bulletin of Experimental Biology and Medicine, 2002, 133(4), 426-428.
16. Roberta Budriesi, Pierfranco Ioan, Alessandra Locatelli.Imidazo[2,1-b]thiazole System: A Scaffold Endowing Dihydropyridines withSelective Cardiodepressant Activity. J. Med. Chem. 2008, 51, 1592-1600
17. Hantsch, A. et al. Hantzsch pyridine synthesis. Ann Chem.,1882,215,1-81.
18. D.R. Harish kumar, Nayeem Naira et. al. Synthesis and invitro calcium channelblocking activity of symmetrical and unsymmetrical substituted 1,4- dihydropyridines. Asian journal of Chemistry, 2009, vol 6, 21,4357-4365.
19. V. M. Markhele, S.A. Sadaphal and M. S. Shingare. An Efficient One-Pot Synthesis of Polyhydroquinolines at RoomTemperature Using MCM-41 catalyst under solvent-freeconditions. Bulletin of the Catalysis Society of India, 6 (2007) 125-131.
20. Mustafa Arslan, et. al. An efficient one pot synthesis of 1,4-dihydropyridines usingalumina sulfuric acid (ASA) catalyst. Turk J Chem 33 (2009), 769-774.
21. Shu-Xiang Wang, Zhi-Yan Li, Jin-Chao Zhang, Ji-Tai Li. The solvent-free synthesis of 1,4-dihydropyridines under ultrasound irradiation without catalyst. UltrasonicsSonochemistry 15 (2008) 677-680
22. David J. Triggle. 1,4-Dihydropyridines as Calcium Channel Ligands and PrivilegedStructures Cellular and Molecular Neurobiology. June 2003,23(3),293-303.
23. Nicoletta Pedemonte, Davide Boido. Structure-Activity Relationship of 1,4- dihydropyridinesas potentiators of the cftr chloride channel. Molecular Pharmacology Fast Forward, 2007.
24. Kalam Sirisha, Garlapati Achaiah, and Vanga Malla Reddy. Facile Synthesis and Antibacterial, Antitubercular, and Anticancer Activities of Novel 1,4-Dihydropyridines. Arch. Pharm. Chem. Life Sci. 2010, 343, 342-352
25. Atul. T. Manvar, Raghuvir.R. S. Pissurlenkar;. Synthesis, in vitro antitubercular activity and 3D-QSAR study of 1,4-dihydropyridines, Mol Divers, 2010, 14, 285-305.
26. Bhavik Desai, Dinesh Sureja, Yogesh Naliapara, Anamik Shaha and Anil K. Saxena. Synthesis and QSAR Studies of 4-Substituted Phenyl-2,6-dimethyl-3, 5-Bis-N- (substituted Phenyl)carbamoyl-1,4- dihydropyridines as Potential Antitubercular Agents. Bioorganic & Medicinal Chemistry, 2001, 9, 1993-1998.
27. 5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides, European Journal of Medicinal Chemistry, 2009, 44, 3253-3258.
28. Amini M, Navidpour L, Shafiee A. Synthesis and antitubercular activity of new N,N-diaryl-4-(4,5-dichloroimidazole-2-yl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxamides, DARU, 2008, 16(1), 9-12.
29. 5-Diaryl-4-(5-arylisoxazol-3-yl)-1, 4- dihydropyridine-3, 5-dicarboxamide. Journal of Sciences, Islamic Republic of Iran, 2008, 19(4), 323-328.
30. Sushil, K. Dubey and Edward, E. Knaus. Synthesis of heterocyclic 1,4- dihydropyridylacetic acid derivatives of 6-aminopenicillanic acid and D-aaminobenzylpenicillin with antibacterial activity. Can. J. Chem., 1984, 62, 559.
31. Mithlesh, Pawan.K. Pareek, Ravi Kant, Sanjeev.K. Shukla, Krishan G. Ojha. Rapid synthesis and biological evaluation of 1, 4- dihydropyridine derivatives containing a benzothiazolyl moiety. Cent. Eur. J. Chem, 2010, 8(1), 163-173.
32. Anil K. Chhillar, Pragya. Arya. Microwaveassisted synthesis of antimicrobial dihydropyridines and tetrahydropyrimidin-2-ones: Novel compounds against aspergillosis. Bioorganic & Medicinal Chemistry, 2006, 14, 973-981.
33. Rakesh kumar, sakshi malik, & Ramesh Chandra. synthesis and antimicrobial activity of 4-[5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl]-1,4-dihydropyridines and 4-[5-chloro-3-methyl-1-phenyl-1H-pyrazol-4-yl]-3,4-dihydropyrimidin-2-ones. Indianjournal of chemistry, May2009, 48, 718-724.
34. Simona Saponara, Antonella Ferrara, Beatrice Gorelli, Anamik Shah.3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine(DP7): A new multidrug resistance inhibitor devoid of effects onLangendorff-perfused rat heart. European Journal of Pharmacology 2007, 563, 160-163.
35. Masami Kawase, Anamik Shah, Harsukh Gaveriya, Noboru Motohashi, Hiroshi Sakagami, Andreas Vargae and Joseph Molna R. 3,5-Dibenzoyl-1,4-dihydropyridines: Synthesis and MDR Reversal in Tumor Cells, Bioorganic & MedicinalChemistry, 2002, 10 1051-1055.
36. Shigeyuki Tasaka, Hiromasa Ohmori, Noriaki Gomi, Mayumi Iino, Tosiki Machida, Akira Kiue, Seiji Naito and Michihiko Kuwanoc.Synthesis and Structure Activity Analysis of Novel Dihydropyridine Derivatives to Overcome Multidrug Résistance. Bioorganic & Medicinal Chemistry Letters, 2001, 11, 275-277.
37. Nadezhda I. Ryabokona, Nataliya V. Nikitchenkob, Olga V. Dalivelyab, Rose I. Goncharovab, Gunars Dubursc, Maria Konopackaa, Joanna Rzeszowska-Wolnya. Modulation of cellular defense processes in human lymphocytes in vitro by a1,4-dihydropyridine derivative, Mutation Research, 2009, 679, 33-38.
38. Béatrice Marquez, Luc Neuville, Nicole J. Moreau, Jean-Pierre Genet, Aldenir Feitosa dos Santos. Multidrug resistance reversalagent from Jatropha elliptica, Phytochemistry, 2005, 66,1804-1811.
39. Gunars Tirzitis, Dace Tirzitis and Zhanna Hyonen. Antioxidant activity of 2,6-dimethyl-3,5-dialkyloxycarbonyl-1,4-dihydropyridines in metal ion catalysed lipid peroxidation, Czech.J.Food Sci, 2001, 19(3), 81-84.
40. D. Tirzite, A. Krauze, A. Zubareva, G. Tirzitis, and G. Duburs. Synthesis and Antiradical activity of 5-acetyl-2-alkylthio-4- aryl- 6-methyl-1,4-dihydropyridine-3- carboxylic acid nitriles, Chemistry of Heterocyclic Compounds, 2002, 38(7), 795-800.
41. Atul Kumar, Ram Awatar Maurya, Siddharth Sharma, Mukesh Kumar, Gitika Bhatia. Synthesis and biological evaluation of N-aryl-1, 4-dihydropyridinesas novelantidyslipidemic and antioxidant agents, European Journal of Medicinal Chemistry, 2010, 45, 501-509.
42. Toshihisa Ogawa, Atsuro Nakazato, Katsuharu Tsuchida, and Katsuo Hatayama.Synthesis and antihypertensive activity of new 1,4-dihydropyridine derivatives containing nitrooxyalkylester moieties at the 3- and 5-position, chem.Pharm.Bull., 1993, 41(6), 1049-1054.
43. Ali Akbar Nekooeian, Azadeh Khalili, Katayoun Javidnia, Ramin Miri. Antihypertensive effect of some new nitroxyalkyl 1,4-dihydropyridines derivativesin rat model of two-kidney, one clip hypertension,. Iranian journal of pharmaceutical reaserch,2009, 8(3), 193-199.
44. F. Hadizadeh, Z. Fatehi-Hassanabad, M. Fatehi-Hassanabad, and F. Nabati. synthesis and antihypertensive activity of novel 4-[1-(4-x-benzyl)-5-imidazol yl] dihydropyridines in rat, Reaserch in pharmaceutical sciences, oct 2007,2(2),85-90.
45. Seimei Osumi, Shigeyoshi Morishita, Katsuo Wada, Hachiro Usui, Mamoru Kanda, Hiroshi Matsui. Antihypertensive Effect of NKY-722, a new water-soluble 1,4-dihydropyridine derivative, on conscious spontaneously hypertensive rats, Tohoku J. exp. Med,1988, 155, 205-206.
46. Muto K, Kuroda T, Kawato H, Karasawa A, Kubo K, Nakamizo N. Synthesis andpharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)- 3,5-pyridine-dicarboxylic acid methyl 1- (phenylmethyl)-3-piperidinyl ester, Arzneimittelforschung. 1988 Nov, 38(11A), 1662-5.
47. Kanno H, Yamaguchi H, Okamiya Y, Sunakawa K, Takeshita. synthesis and antihypertensive activity of 3-[4-(substituted amino) phenylalkyl]ester derivatives, chem. Pharm bull (Tokyo),1991,39(1),91-99.
48. Kanno h, yamaguchi. synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl)ring and an amino alkyl ester group: highly potent and long- lasting calcium antagonists, Chem.Pharm Bull(Tokyo) 1992, Aug, 40(8), 2049-54.
49. Kobayashi T. Inoue Y. synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridines derivatives having nitroxyalkoxycarbonyl groups at 3-and/or 5-position, Chem. Pharm bull (Tokyo), 1995, May, 43(5),788-96.
50. D.R Harish Kumar, Nayeem Naira, Manjunath Gahate. Synthesis and invitro calcium channel blocking activity of symmetrical and asymmetrical substitution of1,4-dihydropyridine derivatives. Asian Journal Of Chemistry, 2009, 21(6), 4357-4365.
51. N. Daryabari, T. Akbarzadesh. synthesis and calcium antagonist activity of new derivatives of dialkyl 1,4-dihydro-2,6-dimethyl-4-(5-phnylisoxazol-3-yl)pyridine-3,5-dicarboxylate J. Iran. Chem. Soc., march 2007,4(1),30-36.
52. Ramin Miri, Katayoun Javidnia, Hasti Sarkarzadeh and Bahram Hemmateenejada. Synthesis, study of 3D structures, andpharmacological activities of lipophilicnitroimidazolyl-1,4-dihydropyridines ascalcium channel antagonist, BMC, 2006, 14, 4842-4849.
53. R. Fossheim, A. Joslyn, A. J. Solo, E. Luchowski, A. Rutledge and D. J. Triggle. Crystal Structures and PharmacologicActivities of 1,4-Dihydropyridine CalciumChannel Antagonists of the Isobutyl Methyl 2,6-Dimethyl-4-(substitutedphenyl)-1,4- dihydropyridine-3,5-dicarboxylate(Nisoldipine) Series. Journal of Medicinal Chemistry, 1988, 31(2),300-305.
54. A. Zarghi, H. Sadeghi, A. Fassihi, M. Faizi, A. Shafiee. Synthesis and calcium antagonist activity of 1,4-dihydropyridines containing phenylaminoimidazolyl substituents. Il Farmaco, 2003, 58, 1077-1081.
55. Shashikant R Pattan, Nachiket S. Dighe, Deepak S Musmade, Snehalata K. Tambe, Suwarna H Kale, Vinayak M Gaware and Prerna A Chavan. Synthesis and evaluation of some new substituted 1,4-dihydropyridinederivatives and their anticonvulsant activity. J. Chem. Pharm. Res., 2010, 2(1), 246-252.
56. Abbas Shafiee, Noushin rastkari, Mohammad Sharifzadeh. Anticonvulsant activities of new 1,4-dihydropyridine derivatives containing 4-nitroimidazolyl substituents. DARU, 2004 12(2), 81-86.
57. Brijeshkunvar Mishra and Richa Mishra. Synthesis of some 1, 4-dihydropyridine derivatives for anti-inflammatory activity, ThePharmacist, 2007, 2(1), 13-16.
58. B B Subudhi and P K Panda. Synthesis antiulcer activity of 1,4-dihydropyridines and their mannich bases with sulfanilamide. Indian Journal Of Chemistry, 2009,48B, 725-728.